1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W et al SEER Cancer Statistics Review, 1975–2008, National Cancer Institute, Bethesda, MD. Available at:
http://seer.cancer.gov/csr/1975_2008/
, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
2. American Cancer Society. Prostate cancer survival rates. Last Medical Review: 22/12/2014. Last Revised: 12/03/2015. Available from
http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-survival-rates
.
3. Coleman RE . Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12: 6243s–6249s.
4. Weinfurt KP, Li Y, Castel LD, Timbie JW, Glendenning A, Schulman KA . The impact of skeletal-related events on health-related quality of life of patients with metastatic prostate cancer [abstract 662P]. Ann Oncol 2002; 13: 180.
5. Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 2006; 12: 6213s.